Authors : Reem Saad; Alizeh Ahmad; Sana Khalid

Volume/Issue : Volume 7 - 2022, Issue 3 - March

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/3r8Kp4x

DOI : https://doi.org/10.5281/zenodo.6418403

Abstract : - Globally, noncommunicable diseases (NCDs), also termed as chronic conditions, account for a disproportionate number of deaths annually. The main types of NCDs are cardiovascular, cancers, chronic respiratory conditions, and diabetes. These diseases kill approximately 41 million individuals annually and account for 71% of overall deaths. Despite amounting evidence showing the socio-economic impact of these manageable conditions, the global call to action remains less than adequate [1]. Chronic diseases are defined as health conditions lasting for over one year or more. Chronic diseases such as diabetes are associated with repeated hospitalizations and pose a grave public health challenge [2]. During the COVID-19 pandemic, reducing hospitalizations due to chronic diseases became necessary, which led to the emergence of non-invasive remote monitoring. Research has consistently shown that remote monitoring helps in achieving better glycemic control in patients with diabetes [3]. The Health Bank (THB), a global healthcare company, conducted a pilot study “THB Connected Care Program” to examine the relationship between remote monitoring and patient outcomes in patients with chronic conditions, focusing on diabetes. Patients were remotely monitored using a variety of devices (iHealth glucometer, Freestyle Libre, and Medtronic – Guardian Connect) for a period of three months. The results of our study suggest that remote monitoring helps in achieving improved patient engagement and better parameter outcomes. This pilot serves as a foundation for further studies that can help in the wider adoption of remote monitoring in persons with chronic conditions.